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Introduction
Methotrexate is the most used DMARD drug in the
treatment of juvenile idiopathic arthritis and its efficacy
has been demonstrated for more than 20 years. The
usual dose is 10 to 15mg/m2/week. It is a safe and well-
tolerated drug by children and the most common side
effects are gastrointestinal, hematologic and liver toxicity.
Objectives
To report a case of a 13-years old adolescent girl diag-
nosed with polyarticular JIA that had an anaphylactic
reaction to the first dose of subcutaneous methotrexate.
Methods
Case report and literature review.
Results
A 13-years old adolescent girl diagnosed with polyarticu-
lar JIA (RF +/ANA-/HLA-B27-) received the first dose of
subcutaneous methotrexate in our Day Care centre due
to refractoriness to NSAIDs. While she was leaving the
building after 10 minutes of medication she developed
urticaria, angioedema, shortness of breath and hypoxia
(O2 saturation of 85%). After administration of 0.5ml of
1:1000 adrenaline, 500ml of saline, 2.5mg of dexchlor-
pheniramine and 125mg of methylprednisolone she
recovered and was discharged home after a short period
of stay. The methotrexate she used was also for intrathe-
cal administration and had only distilled water as
suspension.
Conclusion
This is the first case report of anaphylaxis to methotrex-
ate in a patient with JIA without previous exposure. Con-
sidering it is a very rare and fatal reaction, we suggest
that the first subcutaneous dose should be administrated
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